| (Values in U.S. Thousands) | Mar, 2022 | Dec, 2021 | Sep, 2021 | Jun, 2021 | Mar, 2021 |
| Sales | 48,850 | 49,780 | 48,680 | 48,810 | 50,600 |
| Sales Growth | -1.87% | +2.26% | -0.27% | -3.54% | +13.53% |
| Net Income | 17,340 | 21,060 | 19,520 | 21,130 | 21,590 |
| Net Income Growth | -17.66% | +7.89% | -7.62% | -2.13% | +20.82% |
Global Cord Blood Corp (CO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China.